U.S. Cord Blood Banking Services Market (By Bank Type; By Component: Cord Blood, Tissue, Placenta; By States: Texas, Arizona, California, Florida, Kentucky, New Jersey) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2025-2034

U.S. Cord Blood Banking Services Market Size, Share, Report 2025-2034

The U.S. Cord blood banking services market size was estimated at USD 1.05 billion in 2024 and it is projected to hit around USD 1.65 billion by 2034, growing at a CAGR of 4.6% from 2025 to 2034. 

Key Pointers 

• By bank type, the private bank type segment generated the maximum market share of 98% in 2024.
• By bank type, the hybrid bank segment is predicted to grow at the remarkable CAGR of 12.04% from 2025 to 2034.
• By component, the cord blood (CB) segment contributed the largest market share of 51% in 2024.
• By component, the cord tissue component segment is anticipated to grow at the noteworthy CAGR during the forecast period.
• By states, the california segment registered the maximum market share of 18.4% in 2024.

Report Scope of the U.S. Cord Blood Banking Services Market

U.S. Cord Blood Banking Services Market Overview 

The U.S. cord blood banking services market has seen steady growth in recent years, driven by rising awareness about the long-term therapeutic potential of stem cells derived from umbilical cord blood. These services involve the collection, processing, and storage of cord blood for future medical use, particularly in the treatment of various blood disorders, genetic diseases, and immune deficiencies. The increasing prevalence of chronic and rare diseases, advancements in stem cell research, and growing acceptance of regenerative medicine have significantly contributed to the market’s expansion.

What are the Growth Factors of U.S. Cord Blood Banking Services Market? 

The growth of the U.S. cord blood banking services market is primarily fueled by the increasing recognition of cord blood as a valuable source of hematopoietic stem cells, which are used in the treatment of over 80 medical conditions, including leukemia, lymphoma, and sickle cell anemia. Rising awareness among expecting parents, driven by educational campaigns and healthcare provider recommendations, has significantly boosted the adoption of both private and public cord blood banking.

Another key driver is the growing investment in regenerative medicine and stem cell research, which continues to broaden the therapeutic potential of cord blood beyond traditional hematologic disorders. The increasing incidence of chronic and genetic diseases, along with a rising birth rate among health-conscious parents, has created a favorable environment for market expansion.

What are the Trends in U.S. Cord Blood Banking Services Market? 

• Rising Preference for Private Cord Blood Banking: Increasing awareness about family-specific stem cell therapies has led to a higher demand for private banking, as parents seek long-term health security for their children.
• Advancements in Stem Cell Applications: Ongoing research is expanding the use of cord blood stem cells in regenerative medicine, including neurological, cardiovascular, and autoimmune conditions, driving broader interest in storage.
• Integration of AI and Digital Platforms: Cord blood banks are adopting AI-driven tools and digital health platforms to enhance donor tracking, sample management, and customer engagement, streamlining the overall banking experience.

What are the Key Challenges Faced by U.S. Cord Blood Banking Services Market? 

One of the major challenges confronting the U.S. cord blood banking services market is the high cost associated with private banking. The initial collection, processing, and long-term storage fees can be financially burdensome for many families, making it less accessible to the broader population. Additionally, insurance coverage for cord blood storage is limited, and the relatively low probability of actually using the stored cord blood for treatment contributes to hesitancy among potential customers. This cost-benefit uncertainty often steers families toward public banking or away from banking entirely, impacting the growth of private service providers.

Another significant obstacle is the limited utilization of stored cord blood units. Despite the growing number of samples banked annually, only a small fraction is ever used for transplantation or therapy, raising concerns about the practical value of storage. Moreover, public awareness of the full potential and limitations of cord blood applications remains uneven, leading to misconceptions and underutilization.

Segmental Insights

Bank Type Insights

The private bank type segment held the dominant share, accounting for over 98% of the market in 2024. Private banks operate by storing the cord blood exclusively for the donor family, offering a sense of assurance in case of medical needs related to stem cell therapy. The rising awareness of stem cell treatments, coupled with the growing prevalence of genetic and blood-related disorders, has encouraged more families to opt for private banking. Moreover, advancements in processing technologies and improved service offerings, such as flexible payment plans and enhanced storage safety, have made private banks a more attractive option.

The hybrid bank segment is projected to witness the highest CAGR of 12.04% between 2024 and 2034. These banks allow families to store a portion of the cord blood for personal use while contributing the remaining portion to a public registry, enabling potential use by others in need. This dual-purpose approach appeals to families who value both personal security and social contribution. The hybrid model offers a cost-effective solution and increases the likelihood of stored units being used, which addresses one of the major challenges in the industry underutilization.

Component Insights

The cord blood (CB) led the industry, contributing over 51% of the total revenue in 2024. The U.S. cord blood banking services market, the cord blood (CB) component continues to be the cornerstone of storage services due to its rich source of hematopoietic stem cells. These stem cells are widely used in the treatment of various blood-related disorders, including leukemia, lymphoma, and certain immune and metabolic diseases. The clinical success of cord blood transplants has significantly boosted demand for its preservation, particularly among families with a history of such conditions. 

The cord tissue component segment is projected to experience the highest growth rate over the forecast period. Cord tissue contains mesenchymal stem cells (MSCs), which are known for their regenerative capabilities and potential to treat a wider range of conditions such as orthopedic injuries, neurological disorders, and autoimmune diseases. Although cord tissue applications are still largely in the research and clinical trial stages, increasing interest in its therapeutic promise has led many private banks to offer dual storage options. This has not only expanded the scope of services but also allowed families to invest in the future of personalized medicine.

States Insights

The california led the overall market, contributing over 18.4% of the total revenue in 2024. California represents one of the most prominent and rapidly growing markets in the U.S. cord blood banking services sector, driven by its large population, advanced healthcare infrastructure, and high level of public awareness. The state benefits from a strong network of hospitals, birthing centers, and healthcare professionals who actively promote the importance of cord blood and tissue banking.

The increasing prevalence of chronic and genetic disorders in the state has also contributed to a growing demand for both private and hybrid cord blood banking services. Parents in California, particularly in urban and affluent areas, are more inclined to invest in future health preparedness through personalized stem cell storage. Moreover, the state has supportive policies and a progressive regulatory environment that encourage innovation and participation in biomedical advancements.

Top Companies in U.S. Cord Blood Banking Services Market

• Cord Blood Registry (CBR)
• Cryo-Cell International, Inc.
• ViaCord (a division of PerkinElmer)
• Americord Registry LLC
• LifeCell International Pvt. Ltd.
• StemCyte Inc.
• AlphaCord LLC
• FamilyCord
• Global Cord Blood Corporation
• Vitalant (formerly BloodSource)

Market Segmentation    

By Bank Type 

• Private
• Public
• Hybrid

By Component Scope 

• Cord Blood
• Cord Tissue
• Placenta

By Regional 

• Arizona
• California
• Florida
• Kentucky
• New Jersey
• Texas
• Massachusetts